• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死年轻幸存者中巨核细胞-血小板再生时间缩短。

Shortened megakaryocyte-platelet regeneration time in young survivors of myocardial infarction.

作者信息

Hamsten A, Svensson J, Walldius G, Szamosi A, de Faire U

出版信息

Am Heart J. 1985 Dec;110(6):1154-60. doi: 10.1016/0002-8703(85)90005-5.

DOI:10.1016/0002-8703(85)90005-5
PMID:2866703
Abstract

Megakaryocyte-platelet regeneration time (MPRT) was determined 6 to 12 months after myocardial infarction in 42 patients below the age of 45 years (mean age +/- SD = 39.4 +/- 4.6, range 23 to 44) and in 11 healthy control subjects by measurement of the reappearance rate of platelet cyclooxygenase activity after oral aspirin. In the young post infarction patients, MPRT was correlated to pertinent metabolic, angiographic, and clinical findings. MPRT for all patients tended to be shorter than in control subjects (t1/2 = 4.53 +/- 1.15 vs 5.22 +/- 0.52; p less than 0.10). Age, present tobacco consumption, serum lipoprotein lipid concentrations, and glucose tolerance, as well as other measured risk factors, did not correlate significantly with MPRT. A marked difference in MPRT, independent of risk factor profile, was present between patients with and without hemodynamically significant stenoses in the coronary angiogram (4.06 +/- 0.92 vs 5.22 +/- 1.07; p less than 0.001). It is suggested that a shortened platelet survival in young post infarction patients is secondary to platelet activation by high-velocity flow and shear forces at the sites of proximal coronary artery stenoses.

摘要

在42名年龄小于45岁(平均年龄±标准差 = 39.4±4.6,范围23至44岁)的心肌梗死患者以及11名健康对照者中,通过测量口服阿司匹林后血小板环氧化酶活性的再现率,在心肌梗死后6至12个月测定巨核细胞 - 血小板再生时间(MPRT)。在年轻的心肌梗死后患者中,MPRT与相关的代谢、血管造影和临床发现相关。所有患者的MPRT往往比对照者短(t1/2 = 4.53±1.15对5.22±0.52;p<0.10)。年龄、当前烟草消费量、血清脂蛋白脂质浓度和葡萄糖耐量以及其他测量的危险因素与MPRT均无显著相关性。在冠状动脉造影中有或无血流动力学显著狭窄的患者之间,MPRT存在明显差异,与危险因素谱无关(4.06±0.92对5.22±1.07;p<0.001)。提示年轻心肌梗死后患者血小板存活时间缩短是由于冠状动脉近端狭窄部位的高速血流和剪切力导致血小板活化所致。

相似文献

1
Shortened megakaryocyte-platelet regeneration time in young survivors of myocardial infarction.心肌梗死年轻幸存者中巨核细胞-血小板再生时间缩短。
Am Heart J. 1985 Dec;110(6):1154-60. doi: 10.1016/0002-8703(85)90005-5.
2
The use of monoamine oxidase inhibition to estimate megakaryocyte-platelet regeneration time (MPRT).使用单胺氧化酶抑制法估计巨核细胞-血小板再生时间(MPRT)。
Thromb Res. 1988 Feb 15;49(4):425-35. doi: 10.1016/0049-3848(88)90245-9.
3
A method for measurement of platelet regeneration in man.一种测量人体血小板再生的方法。
Prostaglandins Med. 1978 Dec;1(6):455-60. doi: 10.1016/0161-4630(78)90116-7.
4
[Platelet activation in young men after myocardial infarction: its relation to metabolic coronary risk factors].
Kardiol Pol. 1992 Jun;36(6):341-6.
5
Arachidonic acid metabolism and inhibition of cyclooxygenase in platelets from asthmatic subjects with aspirin intolerance.阿司匹林不耐受哮喘患者血小板中花生四烯酸代谢与环氧化酶抑制作用
Ann Allergy. 1985 Feb;54(2):158-60.
6
Platelets and prostaglandins in sudden death: therapeutic implications.
Cardiovasc Clin. 1985;15(3):65-80.
7
Determination of platelet-megakaryocyte regeneration time in painters occupationally exposed to organic solvents.职业性接触有机溶剂的油漆工血小板-巨核细胞再生时间的测定
J Chromatogr. 1986 Oct 31;382:67-77. doi: 10.1016/s0378-4347(00)83505-7.
8
Inhibition of platelet prostaglandin synthetase by oral aspirin.口服阿司匹林对血小板前列腺素合成酶的抑制作用。
J Clin Invest. 1978 Feb;61(2):314-9. doi: 10.1172/JCI108941.
9
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.尿毒症患者血小板血栓素生成减少。环氧化酶功能缺陷的证据。
J Clin Invest. 1983 Mar;71(3):762-8. doi: 10.1172/jci110824.
10
Arachidonic acid metabolism in the neonatal platelet.新生儿血小板中的花生四烯酸代谢
Pediatrics. 1982 Jun;69(6):714-8.

引用本文的文献

1
The p48_HPC antithrombogenic flow diverter: initial human experience using single antiplatelet therapy.p48_HPC抗血栓形成血流转向装置:单药抗血小板治疗的初步人体经验。
J Int Med Res. 2020 Jan;48(1):300060519879580. doi: 10.1177/0300060519879580. Epub 2019 Oct 15.
2
Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.稳定型冠状动脉疾病患者阿司匹林抗血小板作用降低的决定因素。
PLoS One. 2015 May 18;10(5):e0126767. doi: 10.1371/journal.pone.0126767. eCollection 2015.
3
Aspirin resistance: current status and role of tailored therapy.
阿司匹林抵抗:现状与个体化治疗的作用。
Clin Cardiol. 2012 Nov;35(11):673-81. doi: 10.1002/clc.22031. Epub 2012 Jun 27.
4
[15N tracer technical studies of protein metabolism in arteriosclerosis patients].
Klin Wochenschr. 1990 May 17;68(10):518-22. doi: 10.1007/BF01648246.
5
Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.
Eur J Clin Pharmacol. 1992;42(4):413-21. doi: 10.1007/BF00280128.